A9.14 Regulatory T Cell Abnormalities in Patients with SLE Suggest an IL-2-Based Immunotherapy

C von Spee; N Wassermann; JY Humrich; G Riemekasten

doi:10.1136/annrheumdis-2013-203223.14

Article info

PDF

9. Novel therapeutic targets

A9.14 Regulatory T Cell Abnormalities in Patients with SLE Suggest an IL-2-Based Immunotherapy

Free

Authors

C von Spee 1German Rheumatism Research Centre, Berlin, Germany2Charité University Hospital, Rheumatology and Clinical Immunology, Berlin, Germany. PubMed articles Google scholar articles
N Wassermann 2Charité University Hospital, Rheumatology and Clinical Immunology, Berlin, Germany. PubMed articles Google scholar articles
JY Humrich 1German Rheumatism Research Centre, Berlin, Germany2Charité University Hospital, Rheumatology and Clinical Immunology, Berlin, Germany. PubMed articles Google scholar articles
G Riemekasten 1German Rheumatism Research Centre, Berlin, Germany2Charité University Hospital, Rheumatology and Clinical Immunology, Berlin, Germany. PubMed articles Google scholar articles

Citation

Spee CV, Wassermann N, Humrich J, et al

A9.14 Regulatory T Cell Abnormalities in Patients with SLE Suggest an IL-2-Based Immunotherapy

Annals of the Rheumatic Diseases 2013;72:A69-A70.

Publication history

First published February 25, 2013.

Online issue publication

October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password